Nanomedicine News

RSS

Nanotechniques Developed in Space Could Help Better Understand Deep Brain Stimulation

Applying nanotechniques developed in the U.S. space program may help to better understand the electrochemical dynamics of deep brain stimulation in order to fine-tune the therapy, according to a presentation by NASA Ames Research Center scientist Russell J. Andrews, M.D., at the International Neuromodulation Society’s 12th World Congress.

9 Jun 2015

Graphene-Coated Catheters May Improve Delivery of Chemotherapy Drugs

A new study published in IOP Publishing's journal 2D Materials has proposed using graphene as an alternative coating for catheters to improve the delivery of chemotherapy drugs.

3 Jun 2015

Global Antiviral Therapeutics Report Features Potential for Nanotechnology in Virology

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.

2 Jun 2015

Dicerna’s DCR-MYC Demonstrates Clinical Anti-Tumor Activity Against Advanced Pancreatic Neuroendocrine Tumors

Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced solid tumors, multiple myeloma, or lymphoma at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

2 Jun 2015

Advances in Nanotechnology’ Event at Birmingham UK from 9 June

New technologies designed to eliminate cancers and aid surgical procedures are to be explored at an international nanotechnology conference in Birmingham next month.

1 Jun 2015

LD Micro Invitational: Matinas BioPharma to Present on Targeted Therapeutics

Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company principally focused on the development of targeted therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the LD Micro Invitational being held June 1-3, 2015, at the Luxe Sunset Boulevard, Los Angeles, CA.

29 May 2015

Malvern's Nanoparticle Tracking Analysis Used in Development of Targeted microRNA Cancer Therapy at Ohio State University

Researchers in the Department of Chemical and Biomolecular Engineering at The Ohio State University (Columbus, Ohio, USA) are using Malvern Panalytical’ NanoSight Nanoparticle Tracking Analysis (NTA) to study extracellular vesicle yields from different cell culture lines.

From Malvern Panalytical 28 May 2015

Drug-Releasing, Multi-Tasking Electronic Stent Could Help Minimize Risks

Every year, an estimated half-million Americans undergo surgery to have a stent prop open a coronary artery narrowed by plaque. But sometimes the mesh tubes get clogged. Scientists report in the journal ACS Nano a new kind of multi-tasking stent that could minimize the risks associated with the procedure. It can sense blood flow and temperature, store and transmit the information for analysis and can be absorbed by the body after it finishes its job.

From American Chemical Society 28 May 2015

Revolutionary Nanotechnology Could Help Prevent Deep Bone Infections

Leading scientists at the University of Sheffield have discovered nanotechnology could hold the key to preventing deep bone infections, after developing a treatment which prevents bacteria and other harmful microorganisms growing.

28 May 2015

Eighteen Studies Utilizing Nanosphere Verigene Multiplex Infectious Disease Tests Presented at CVS, ECCMID, and MAD-ID

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by various U.S. and international hospitals were recently presented at the annual Clinical Virology Symposium (CVS) in Daytona Beach, Florida, the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark, and the Making a Difference in Infectious Diseases (MAD-ID) Conference in Orlando, Florida.

28 May 2015